Cargando…
Targeted micelles with chemotherapeutics and gene drugs to inhibit the G1/S and G2/M mitotic cycle of prostate cancer
BACKGROUND: Chemotherapy and gene therapy are used in clinical practice for the treatment of castration-resistant prostate cancer. However, the poor efficiency of drug delivery and serious systemic side effects remain an obstacle to wider application of these drugs. Herein, we report newly designed...
Autores principales: | Zhang, Yiran, Wang, Yanming, Meng, Li, Huang, Qingqing, Zhu, Yueqi, Cui, Wenguo, Cheng, Yingsheng, Liu, Ranlu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796562/ https://www.ncbi.nlm.nih.gov/pubmed/33422073 http://dx.doi.org/10.1186/s12951-020-00756-6 |
Ejemplares similares
-
Self-assembled mPEG–PCL-g–PEI micelles for simultaneous codelivery of chemotherapeutic drugs and DNA: synthesis and characterization in vitro
por: Shi, Shuai, et al.
Publicado: (2012) -
Gβγ regulates mitotic Golgi fragmentation and G2/M cell cycle progression
por: Rajanala, Kalpana, et al.
Publicado: (2021) -
Polymeric Biodegradable Stent Insertion in the Esophagus
por: Yang, Kai, et al.
Publicado: (2016) -
G-Quadruplexes: From Guanine Gels to Chemotherapeutics
por: Bryan, Tracy M., et al.
Publicado: (2011) -
Contrasting Quiescent G(0) Phase with Mitotic Cell Cycling in the Mouse Immune System
por: Tomura, Michio, et al.
Publicado: (2013)